{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:28:52Z","timestamp":1785446932976,"version":"3.56.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate the result of an inpatient postpartum human papillomavirus (HPV) immunization pilot program in a diverse, low-income patient population from an urban, hospital-based obstetrics and gynecology clinic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>In this cohort study, we present results from the first 2 years of the inpatient postpartum HPV immunization program, in which vaccine-eligible postpartum women were identified and immunized during their hospital stays. The program was implemented after educational outreach with prenatal and postpartum clinicians and nurses. Associations between receipt of the HPV vaccine as an inpatient and the characteristics of patients, and the likelihood of and missed opportunities for receiving a subsequent dose of the HPV vaccine as an outpatient were determined using logistic regression, time-to-event analyses, chi-squared tests and <jats:italic toggle=\"yes\">t<\/jats:italic>-tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>From April 11, 2017, to April 10, 2019, 394 (59.2%) of 666 postpartum women were eligible for the inpatient postpartum HPV immunization program. The majority (265\/394, 67.3%) received the immunization pilot program HPV dose; 36 of those 265 (13.6%) completed the series with that dose. Among women due for additional doses after hospital discharge, those who received the inpatient dose were more likely to receive a subsequent outpatient dose (138\/229) than were those who did not receive an inpatient dose (39\/129; hazard ratio 2.51, 95% CI 1.76\u20133.58). On average, there were 30.7 fewer (95% CI 5.8\u201355.6, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.02) missed opportunities for subsequent outpatient doses for every 100 eligible visits among women who received the inpatient dose, compared with women who did not. By the end of the study, the proportion of women who had completed the vaccine series was higher among women who received the inpatient dose (95\/265, 35.8%) than in those who did not (12 out 129, 9.3%; odds ratio 5.45, 95% CI 2.86\u201310.38).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>The inpatient postpartum HPV immunization program was associated with increased rates of immunization and addressed a previously missed opportunity. Inpatient immunization programs can serve as a critical way to address gaps in vaccine uptake.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000004097","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T22:00:07Z","timestamp":1602194407000},"page":"1006-1015","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of an Inpatient Postpartum Human Papillomavirus Immunization Program"],"prefix":"10.1097","volume":"136","author":[{"given":"Lital","family":"Avni-Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlynn","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Niccolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangini S.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-7-38","article-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease","volume":"7","author":"Serrano","year":"2012","journal-title":"Infect Agent Cancer"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jadohealth.2019.07.003","article-title":"Declines in vaccine-type human papillomavirus prevalence in females across racial\/ethnic groups: data from a national survey","volume":"65","author":"McClung","year":"2019","journal-title":"J Adolesc Health"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ijc.32340","article-title":"Cervical adenocarcinoma in situ: human papillomavirus types and incidence trends in five states, 2008\u20132015","volume":"146","author":"Cleveland","year":"2020","journal-title":"Int J Cancer"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/cid\/cix455","article-title":"Declines in human papillomavirus (HPV)-associated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, United States, 2008-2015","volume":"65","author":"Niccolai","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amepre.2018.03.015","article-title":"Trends in high-grade cervical cancer precursors in the human papillomavirus vaccine era","volume":"55","author":"Oakley","year":"2018","journal-title":"Am J Prev Med"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pvr.2019.04.007","article-title":"Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006\u20132014: the impact of human papillomavirus vaccination","volume":"7","author":"Shing","year":"2019","journal-title":"Papillomavirus Res"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"718","DOI":"10.15585\/mmwr.mm6833a2","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2018","volume":"68","author":"Walker","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/AOG.0000000000000319","article-title":"Factors associated with human papillomavirus vaccination completion on a catch-up schedule","volume":"124","author":"Perry","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R13-20230711","first-page":"1","article-title":"Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Markowitz","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"S408","DOI":"10.1093\/cid\/ciu708","article-title":"Maternal immunization: opportunities for scientific advancement","volume":"59","author":"Beigi","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1097\/AOG.0000000000002588","article-title":"Influenza vaccination during pregnancy. ACOG Committee Opinion No. 732. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1097\/AOG.0000000000002301","article-title":"Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Committee Opinion No. 718. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1016\/j.vaccine.2009.07.030","article-title":"Pertussis immunization in a high-risk postpartum population","volume":"27","author":"Healy","year":"2009","journal-title":"Vaccine"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2017.11.602","article-title":"Missed opportunities for HPV immunization among young adult women","volume":"218","author":"Oliveira","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamapediatrics.2015.0310","article-title":"Practice- and community-based interventions to increase human papillomavirus vaccine coverage: a systematic review","volume":"169","author":"Niccolai","year":"2015","journal-title":"JAMA Pediatr"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"e20182500","DOI":"10.1542\/peds.2018-2500","article-title":"Implementing evidence-based strategies to improve HPV vaccine delivery","volume":"144","author":"Gilkey","year":"2019","journal-title":"Pediatr"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"e20161764","DOI":"10.1542\/peds.2016-1764","article-title":"Announcements versus conversations to improve HPV vaccination coverage: a randomized trial","volume":"139","author":"Brewer","year":"2017","journal-title":"Pediatr"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"e180016","DOI":"10.1001\/jamapediatrics.2018.0016","article-title":"Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial","volume":"172","author":"Dempsey","year":"2018","journal-title":"JAMA Pediatr"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3122\/jabfm.2015.03.140082","article-title":"Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion","volume":"28","author":"Ruffin","year":"2015","journal-title":"J Am Board Fam Med"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1080\/21645515.2015.1125055","article-title":"Interventions to increase HPV vaccination coverage: a systematic review","volume":"12","author":"Smulian","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10900-016-0230-6","article-title":"Improving human papillomavirus (HPV) vaccination in the postpartum setting","volume":"42","author":"Soon","year":"2017","journal-title":"J Community Health"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.vaccine.2018.05.039","article-title":"Impact of a clinical interventions bundle on uptake of HPV vaccine at an ob\/gyn clinic","volume":"36","author":"Deshmukh","year":"2018","journal-title":"Vaccine"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/jiv403","article-title":"Seroprevalence of 9 human papillomavirus types in the United States, 2005\u20132006","volume":"213","author":"Liu","year":"2016","journal-title":"J Infect Dis"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/AOG.0b013e31826afb56","article-title":"Acceptance and compliance with postpartum human papillomavirus vaccination","volume":"120","author":"Wright","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"318.e1","DOI":"10.1016\/j.ajog.2016.02.032","article-title":"A human papillomavirus vaccination program for low-income postpartum women","volume":"215","author":"Berenson","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/cncr.28632","article-title":"The relationship between area poverty rate and site-specific cancer incidence in the United States","volume":"120","author":"Boscoe","year":"2014","journal-title":"Cancer"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"107497","DOI":"10.1155\/2011\/107497","article-title":"Socioeconomic, rural-urban, and racial inequalities in us cancer mortality: part I\u2014all cancers and lung cancer and part II\u2014colorectal, prostate, breast, and cervical cancers","volume":"2011","author":"Singh","year":"2011","journal-title":"J Cancer Epidemiol"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","article-title":"Human papillomavirus-associated cancers\u2014United States, 2008\u20132012","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T21:09:12Z","timestamp":1689109752000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004097","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,6]]}}}